Your browser doesn't support javascript.
loading
A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1-4 hepatitis C virus.
Lawitz, E; Freilich, B; Link, J; German, P; Mo, H; Han, L; Brainard, D M; McNally, J; Marbury, T; Rodriguez-Torres, M.
Affiliation
  • Lawitz E; Texas Liver Institute, University of Texas Health Sciences Center, San Antonio, TX, USA.
  • Freilich B; Kansas City Gastroenterology and Hepatology, Kansas City, MO, USA.
  • Link J; Gilead Sciences, Inc., Foster City, CA, USA.
  • German P; Gilead Sciences, Inc., Foster City, CA, USA.
  • Mo H; Gilead Sciences, Inc., Foster City, CA, USA.
  • Han L; Gilead Sciences, Inc., Foster City, CA, USA.
  • Brainard DM; Gilead Sciences, Inc., Foster City, CA, USA.
  • McNally J; Gilead Sciences, Inc., Foster City, CA, USA.
  • Marbury T; Orlando Clinical Research Center, Orlando, FL, USA.
  • Rodriguez-Torres M; Fundacion De Investigacion, San Juan, Puerto Rico.
J Viral Hepat ; 22(12): 1011-9, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26183611

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Carbamates / Viral Nonstructural Proteins / Hepacivirus / Hepatitis C, Chronic / Heterocyclic Compounds, 4 or More Rings Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2015 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Carbamates / Viral Nonstructural Proteins / Hepacivirus / Hepatitis C, Chronic / Heterocyclic Compounds, 4 or More Rings Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2015 Document type: Article Affiliation country: United States Country of publication: United kingdom